FENC vs MRVL · rev $17.9M vs P/E 100, rev $5.16B
Fennec Pharmaceuticals Inc (FENC) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
FENC currently screens at market cap $302.2M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the FENC and MRVL stock pages for the full models.
Not investment advice.